Therapeutic potential of berberine against neurodegenerative diseases - PubMed (original) (raw)
Review
Therapeutic potential of berberine against neurodegenerative diseases
WenXiao Jiang et al. Sci China Life Sci. 2015 Jun.
Abstract
Berberine (BBR) is an organic small molecule isolated from various plants that have been used in traditional Chinese medicine. Isolation of this compound was its induction into modern medicine, and its usefulness became quickly apparent as seen in its ability to combat bacterial diarrhea, type 2 diabetes, hypercholesterolemia, inflammation, heart diseases, and more. However, BBR's effects on neurodegenerative diseases remained relatively unexplored until its ability to stunt Alzheimer's disease (AD) progression was characterized. In this review, we will delve into the multi-faceted defensive capabilities and bio-molecular pathways of BBR against AD, Parkinson's disease (PD), and trauma-induced neurodegeneration. The multiple effects of BBR, some of which enhance neuro-protective factors/pathways and others counteract targets that induce neurodegeneration, suggest that there are many more branches to the diverse capabilities of BBR that have yet to be uncovered. The promising results seen provide a convincing and substantial basis to support further scientific exploration and development of the therapeutic potential of BBR against neurodegenerative diseases.
Figures
Figure 1
Molecular structure of berberine.
Figure 2
BBR interacts with many pathways that are affiliated with neurodegeneration or neuroprotection.
Similar articles
- Learning from berberine: Treating chronic diseases through multiple targets.
Yao J, Kong W, Jiang J. Yao J, et al. Sci China Life Sci. 2015 Sep;58(9):854-9. doi: 10.1007/s11427-013-4568-z. Epub 2013 Oct 30. Sci China Life Sci. 2015. PMID: 24174332 Review. - Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
Durairajan SS, Liu LF, Lu JH, Chen LL, Yuan Q, Chung SK, Huang L, Li XS, Huang JD, Li M. Durairajan SS, et al. Neurobiol Aging. 2012 Dec;33(12):2903-19. doi: 10.1016/j.neurobiolaging.2012.02.016. Epub 2012 Mar 27. Neurobiol Aging. 2012. PMID: 22459600 - Therapeutic Effect of Berberine on Huntington's Disease Transgenic Mouse Model.
Jiang W, Wei W, Gaertig MA, Li S, Li XJ. Jiang W, et al. PLoS One. 2015 Jul 30;10(7):e0134142. doi: 10.1371/journal.pone.0134142. eCollection 2015. PLoS One. 2015. PMID: 26225560 Free PMC article. - Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics.
Feng X, Sureda A, Jafari S, Memariani Z, Tewari D, Annunziata G, Barrea L, Hassan STS, Šmejkal K, Malaník M, Sychrová A, Barreca D, Ziberna L, Mahomoodally MF, Zengin G, Xu S, Nabavi SM, Shen AZ. Feng X, et al. Theranostics. 2019 Mar 16;9(7):1923-1951. doi: 10.7150/thno.30787. eCollection 2019. Theranostics. 2019. PMID: 31037148 Free PMC article. Review. - Berberine in the Treatment of Neurodegenerative Diseases and Nanotechnology Enabled Targeted Delivery.
Mohi-Ud-Din R, Mir RH, Wani TU, Shah AJ, Banday N, Pottoo FH. Mohi-Ud-Din R, et al. Comb Chem High Throughput Screen. 2022;25(4):616-633. doi: 10.2174/1386207324666210804122539. Comb Chem High Throughput Screen. 2022. PMID: 34348611 Review.
Cited by
- Role of berberine in Alzheimer's disease.
Cai Z, Wang C, Yang W. Cai Z, et al. Neuropsychiatr Dis Treat. 2016 Oct 3;12:2509-2520. doi: 10.2147/NDT.S114846. eCollection 2016. Neuropsychiatr Dis Treat. 2016. PMID: 27757035 Free PMC article. Review. - Berberine Ameliorates Prenatal Dihydrotestosterone Exposure-Induced Autism-Like Behavior by Suppression of Androgen Receptor.
Xiang D, Lu J, Wei C, Cai X, Wang Y, Liang Y, Xu M, Wang Z, Liu M, Wang M, Liang X, Li L, Yao P. Xiang D, et al. Front Cell Neurosci. 2020 Apr 9;14:87. doi: 10.3389/fncel.2020.00087. eCollection 2020. Front Cell Neurosci. 2020. PMID: 32327976 Free PMC article. - Effects of berberine hydrochloride on methamphetamine-induced anxiety behaviors and relapse in rats.
Rezaeian L, Kalalian-Moghaddam H, Mohseni F, Khaksari M, Rafaiee R. Rezaeian L, et al. Iran J Basic Med Sci. 2020 Nov;23(11):1480-1488. doi: 10.22038/ijbms.2020.47285.10884. Iran J Basic Med Sci. 2020. PMID: 33235706 Free PMC article. - A Review on Phyto-Therapeutic Approaches in Alzheimer's Disease.
Sahiner M, Yilmaz AS, Gungor B, Sahiner N. Sahiner M, et al. J Funct Biomater. 2023 Jan 16;14(1):50. doi: 10.3390/jfb14010050. J Funct Biomater. 2023. PMID: 36662097 Free PMC article. Review. - Berberine improves inhibitory avoidance memory impairment of Toxoplasma gondii-infected rat model of ketamine-induced schizophrenia.
Gholizadeh N, Dalimi A, Ghaffarifar F, Nader-Mohammadi M, Molavi P, Dadkhah M, Molaei S. Gholizadeh N, et al. BMC Complement Med Ther. 2023 Aug 30;23(1):303. doi: 10.1186/s12906-023-04107-4. BMC Complement Med Ther. 2023. PMID: 37649038 Free PMC article.
References
- Takase H, Yamamoto K, Ito K, Yumioka E. Pharmacological studies on antidiarrheal effects of berberine and geranii herba (in Japanese) Nihon Yakurigaku Zasshi. 1993;102:101–112. - PubMed
- Kheir MM, Wang Y, Hua L, Hu J, Li L, Lei F, Du L. Acute toxicity of berberine and its correlation with the blood concentration in mice. Food Chem Toxicol. 2010;48:1105–1110. - PubMed
- Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, Wang Y, Wang Z, Si S, Pan H, Wang S, Wu J, Wang Y, Li Z, Liu J, Jiang JD. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med. 2004;10:1344–1351. - PubMed
- Zhang H, Wei J, Xue R, Wu JD, Zhao W, Wang ZZ, Wang SK, Zhou ZX, Song DQ, Wang YM, Pan HN, Kong WJ, Jiang JD. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism. 2010;59:285–292. - PubMed
- Li BX, Yang BF, Zhou J, Xu CQ, Li YR. Inhibitory effects of berberine on IK1, IK, and HERG channels of cardiac myocytes. Acta Pharmacol Sin. 2001;22:125–131. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical